10:52 AM EDT, 03/21/2024 (MT Newswires) -- Andrew Guggenhime, PRESIDENT AND CFO, on March 18, 2024, sold 8,000 shares in Vaxcyte ( PCVX ) for $552,144. Following the Form 4 filing with the SEC, Guggenhime has control over a total of 95,679 shares of the company, with 95,679 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649094/000141588924008745/xslF345X03/form4-03202024_080321.xml

Price: 70.37, Change: +1.24, Percent Change: +1.79